These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 36642778

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE.
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE.
    J Addict Med; 2017 Nov; 11(3):178-190. PubMed ID: 28406856
    [Abstract] [Full Text] [Related]

  • 30. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J, Heilig M, Sarman I.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989
    [Abstract] [Full Text] [Related]

  • 31. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
    Metz V, Jagsch R, Ebner N, Würzl J, Pribasnig A, Aschauer C, Fischer G.
    Hum Psychopharmacol; 2011 Aug 01; 26(6):412-21. PubMed ID: 21823171
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E.
    Drug Alcohol Depend; 2013 Jan 01; 127(1-3):200-6. PubMed ID: 22841456
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE, Finnegan LP, Kaltenbach K.
    Drugs; 2012 Apr 16; 72(6):747-57. PubMed ID: 22512363
    [Abstract] [Full Text] [Related]

  • 39. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
    Serra AE, Lemon LS, Mokhtari NB, Parks WT, Catov JM, Venkataramanan R, Caritis SN.
    Am J Obstet Gynecol; 2017 Apr 16; 216(4):418.e1-418.e5. PubMed ID: 28024988
    [Abstract] [Full Text] [Related]

  • 40. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019.
    Knittel AK, Swartzwelder RA, Zarnick S, Tsujimoto TM, Horne T, Lin FC, Edwards J, Amos E, Alexander J, Thorp J, Jones HE.
    J Addict Med; 2017 Apr 16; 17(5):587-591. PubMed ID: 37788614
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.